BPC-157 is a synthetic peptide studied for potential roles in tissue repair and recovery, particularly in musculoskeletal injuries, based on preclinical research rather than established clinical use
Methylene Blue and Serotonin Syndrome There are two subtypes of MAOIs: MAO-A and MAO-B
Chronic illness, autoimmune dysfunction, frequent infections these peptides retrain immune function rather than suppressing it
I take it you haven't had any more B12 then
Concerns around pleiotropic activity, sourcing variability, and regulatory guidance are valid and underscore the need for ongoing safety monitoring and thoughtful application
Peptide therapy is most relevant for patients managing TMJ disorder, myofascial pain syndrome, periodontal disease, chronic oral inflammation, or those seeking to optimize healing around dental implants or surgical procedures